InvestorsHub Logo
Followers 66
Posts 12740
Boards Moderated 0
Alias Born 06/03/2015

Re: shub post# 84961

Tuesday, 12/20/2016 5:04:29 PM

Tuesday, December 20, 2016 5:04:29 PM

Post# of 463669
Roughly a third of the patients on Aducanumab suffer or have suffered brain swelling. It only moderately slows the decline of the disease.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News